Impact Partnership Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Sell
13,693
-1,548
-10% -$217K 0.24% 55
2025
Q4
$1.87M Sell
15,241
-910
-6% -$111K 0.24% 46
2025
Q3
$1.79M Buy
16,151
+3,013
+23% +$342K 0.27% 38
2025
Q2
$1.46M Buy
13,138
+5,232
+66% +$557K 0.27% 35
2025
Q1
$886K Sell
7,906
-5,044
-39% -$520K 0.19% 55
2024
Q4
$1.2M Buy
12,950
+194
+2% +$17.5K 0.24% 47
2024
Q3
$1.07M Sell
12,756
-198
-2% -$15.1K 0.24% 48
2024
Q2
$889K Sell
12,954
-1,008
-7% -$67.3K 0.23% 52
2024
Q1
$1.02M Buy
13,962
+4,375
+46% +$336K 0.41% 28
2023
Q4
$777K Buy
9,587
+2,742
+40% +$213K 0.28% 46
2023
Q3
$513K Buy
6,845
+2,708
+65% +$208K 0.16% 63
2023
Q2
$319K Buy
+4,137
New +$330K 0.11% 132

Other funds holding GILD

Impact Partnership Wealth's GILD Position: Q1 2026 in Review

Impact Partnership Wealth reduced its Gilead Sciences (GILD) stake by 10% in Q1 2026, selling an estimated $217K and leaving 13,693 shares worth $1.91M. The position accounts for 0.24% of the portfolio, ranked #55.

Impact Partnership Wealth first reported a position in GILD in Q2 2023 and has held it in 12 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Impact Partnership Wealth held 13,693 shares of Gilead Sciences worth $1.91M as of Q1 2026.
  • Impact Partnership Wealth sold 1,548 Gilead Sciences shares in Q1 2026, an estimated $217K.
  • Gilead Sciences made up 0.24% of Impact Partnership Wealth's portfolio in Q1 2026, its #55 holding.
  • Impact Partnership Wealth first reported a position in Gilead Sciences in Q2 2023 and has held it in 12 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.